Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 185

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 185
---
 of Ethereum, bitcoin, BNB, Doge, and other blockchain-linked cryptocurrencies following our purchases of such cryptocurrency with the net proceeds from this offering by the Company and whether the Company is successful in pursuing other strategies to create income streams or otherwise generate funds using its cryptocurrency holdings. Future fluctuations in Ethereum’s, bitcoin’s, BNB’s, Doge’s, and other blockchain-linked cryptocurrencies’ trading prices may result in our converting cryptocurrency purchased with the net proceeds of this offering into cash with a value substantially below the net proceeds from such an offering. There is no assurance that the holders of the foregoing warrants will elect to exercise any or all of such warrants. To the extent that any of the Exchange Warrants, September 2025 Warrants, or November 2025 Warrants are exercised on a “cashless basis,” the amount of cash we would receive from the exercise of such warrants will decrease.

<div align='center'>113</div>

### DETERMINATION OF OFFERING PRICE
The offering price of the shares of Common Stock underlying the Exchange Warrants offered hereby is determined by reference to the exercise price of the Exchange Warrants of $40.00 per share. The exercise price is subject to customary adjustments upon any stock split, stock dividend, stock combination, recapitalization or similar event. The exercise price is also subject to full-ratchet adjustment (down to the Exchange Warrant Exercise Price Floor) in connection with a subsequent offering at a per share price less than the exercise price then in effect. The Exchange Warrant Exercise Price Floor is $36.40 (as adjusted for stock splits, stock dividends, stock combinations, recapitalizations and similar events). Unless stockholder approval is obtained to allow the Exchange Warrants to be exercised at a price that is lower than the Exchange Warrant Exercise Price Floor in accordance with Nasdaq Listing Rules, such exercise price will not be lowered. The Company is under no obligation to seek or obtain such stockholder approval. The Exchange Warrants also provide for a voluntary adjustment to the exercise price, subject to certain conditions set forth therein, including compliance with Nasdaq rules and having obtained the prior written consent of the Required Holders.

We cannot currently determine the price or prices at which shares of our Common Stock may be sold by the Selling Stockholders under this prospectus.

<div align='center'>114</div>

DILUTION If you invest in our Common Stock, your interest will be diluted to the extent of the difference between the Exchange Warrant exercise price per share of Common Stock and the